In partnership with the Symposium on Advanced Wound Care (SAWC), AIROS is proud to support, sponsor, and co-present a Virtual Wound Rounds session on May 27 entitled, “LOVE: Lymphedema. Origin. Venous. Etiology.). Registration is free – learn more today!
We are proud to announce our 2021 Premier Sponsorship of the Lymphology Association of North America® (LANA)! LANA is a non-profit corporation specializing in the certification of healthcare professionals who diagnose and/or treat lymphedema and related disorders.
March is Lymphedema Awareness Month, during which the clinical, patient, and advocacy communities, as well as the private sector, join forces to increase awareness of this chronic condition. We are proud to be partnering with various organizations to do our part in spreading the word.
Despite all the challenges of moving the 2020 National Lymphedema Network (NLN) Conference online, the virtual event was an impressive industry success, and we were thrilled with the results!
The Lymphatic Education & Research Network’s (LE&RN) newly-recognized Centers of Excellence, including a facility at the Children’s Hospital of Philadelphia (CHOP), have been recognized as leaders paving the way for the diagnosis and treatment of lymphatic disease.
AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy products that treat cancer-related lymphedema and venous complications, today announced the launch of its updated AIROS 6 Sequential Compression Therapy device and Arm Plus garments following multiple regulatory approvals.
We are proud to announce that AIROS will again sponsor the annual “Run/Walk to Fight Lymphedema & Lymphatic Diseases,” presented by the Lymphatic Education & Research Network (LE&RN). Actor Kathy Bates is the national spokesperson for LE&RN.
AIROS Medical traveled extensively on the trade show and conference circuit in 2019, generating both brand awareness and clinical interest in compression-related therapy options. Here is a look at some of the medical professionals, clinicians, and patients we had the honor of connecting with last year.